Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, SciBase Holding AB's enterprise value is €16.12 Mil.
SciBase Holding AB's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was €-7.67 Mil. Therefore, SciBase Holding AB's EV-to-EBITDA for today is -2.10.
The historical rank and industry rank for SciBase Holding AB's EV-to-EBITDA or its related term are showing as below:
FRA:5J3'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -11.28 Med: -1.37 Max: 1.03
Current: -2.14
During the past 13 years, the highest EV-to-EBITDA of SciBase Holding AB was 1.03. The lowest was -11.28. And the median was -1.37.
FRA:5J3's EV-to-EBITDA is ranked worse than 100% of 516
companies
in the Medical Devices & Instruments industry
Industry Median: 14.3
vs FRA:5J3: -2.14
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
SciBase Holding AB (FRA:5J3) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
SciBase Holding AB's PE Ratio (TTM) for today is calculated as:
SciBase Holding AB's share price for today is €1.64.
SciBase Holding AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.375.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for SciBase Holding AB's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, SciBase Holding AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SciBase Holding AB EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SciBase Holding AB's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where SciBase Holding AB's EV-to-EBITDA falls into.
SciBase Holding AB's current Enterprise Value is €16.12 Mil.
SciBase Holding AB's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-7.67 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SciBase Holding AB (FRA:5J3) has a EV-to-EBITDA of -2.10 as of Sep. 06, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on SciBase Holding AB. According to the industry distribution chart, SciBase Holding AB ranks #999999 out of 516 companies in the Medical Devices & Instruments industry.
Is SciBase Holding AB's EV-to-EBITDA too high?
SciBase Holding AB's current EV-to-EBITDA is -2.10. Based on the distribution chart, SciBase Holding AB ranks #999999 out of 516 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, SciBase Holding AB has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does SciBase Holding AB's EV-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, SciBase Holding AB ranks #999999 out of 516 companies for EV-to-EBITDA. This places SciBase Holding AB in the lower half of its industry. The industry median EV-to-EBITDA is 14.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.30, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on SciBase Holding AB. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SciBase Holding AB's current EV-to-EBITDA is -2.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SciBase Holding AB stock overvalued right now?
SciBase Holding AB (FRA:5J3) has a current EV-to-EBITDA of -2.10. The stock's GF Value™ is €1.66, compared to a current price of €1.64 — trading 1.2% below its estimated fair value. The current EV-to-EBITDA is -2.10. SciBase Holding AB's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For SciBase Holding AB (FRA:5J3), the current EV-to-EBITDA is -2.10 as of Sep. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SciBase Holding AB (FRA:5J3) Overvalued in 2026?
Based on GuruFocus' analysis, SciBase Holding AB stock appears to be undervalued.
The current stock price of €1.64 is trading 1.2% below its estimated GF Value™ of €1.66.
Key valuation signals for FRA:5J3:
EV-to-EBITDA: -2.10
GF Value™: €1.66 vs. price of €1.64 (1.2% below fair value)
No single metric tells the full story. See the FRA:5J3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SciBase Holding AB is a medical technology company specializing in early detection of skin cancer and prevention in dermatology. SciBase develops, manufactures, and commercializes Nevisense, a point-of-care technology platform that combines AI (artificial intelligence) and EIS technology to elevate diagnostic accuracy and support the prevention of skin diseases. The company's product portfolio consists of the Nevisense platform technology for multiple clinical applications and proprietary Nevisense electrodes. The products are based on measurements using electrical impedance spectroscopy (EIS), analysed using custom artificial intelligence (AI)-based algorithms. The company operates in two segments, which include skin cancer and skin barrier assessment.
63GF Score
Get the complete analysis for FRA:5J3
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:5J3 has been successfully added to your 
